Skip to content

Clinical trials

Active, not recruiting Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Status: Active, not recruiting Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20142
20152
20172
20181
20194
20201
20213
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acerta Pharma BV4
National Cancer Institute (NCI)4
Loxo Oncology, Inc.3
AstraZeneca2
BeOne Medicines2
Janssen Research & Development, LLC2
AbbVie1
BeiGene1
Jurgen Barth1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, Non-Hodgkin6
Hematologic Diseases3
Lymphoma, B-Cell3
Lymphoma, Follicular2
Lymphoma, Mantle-Cell2
Multiple Myeloma2
Anemia1
Bronchiolitis Obliterans Syndrome1
Leukemia1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.